Phoenix Biosystems Competitors

Applied Energy Saving Solutions (AESS) is an Engineering Company specialized in energy saving, energy audits and energy efficiency assessment. We provide our clients with comprehensive service, which allows them to save money by saving energy and protect the environment by reducing CO2 emissions.. Our experience allows us to inspect and evaluate the equipment and systems that consume energy and provide our clients with applicable solutions that increase the efficiency of these systems and reduce their energy consumption. AESS is run by qualified and experienced people who understand the operation of the various systems in the buildings, which allows us to give reasonable assumptions and perform energy saving calculations.

VitroFlora is a commercial producer of premium plant tissue cultures for agriculture and horticulture sectors, including nursery and landscaping, timber and forestry, land regeneration, and edible crops (fruit, nuts, sugar cane). VitroFlora also offers a range of horticultural services including contract research & development, Plant Breeders Rights applications, contract deflasking, tissue culture propagation, revegetation consultancy. VitroFlora offers next-day delivery to Australian airports.

Clinical Cell Culture (C3) is a company listed on the Australian Stock Exchange (ASX Code CCE) that was established to commercialise a number of autologous tissue engineered products for autologous cell replacement. C3 is able to provide culture services from laboratories based in Australia and Europe and is expanding their sales, marketing and clinical support programme throughout the world. This has been achieved by employing expert staff in Australia and Europe who are recruiting specialised distributors globally. Whilst now a commercial entity with operations in Asia-Pacific and Europe, C3 remains committed to the further development of autologous tissue technologies. Ongoing research will result in a pipeline of innovative products that will be used to optimise patients' outcomes. The use of collaborations with key research groups such as the McComb Foundation will ensure C3 research remains at the forefront of technology. C3 is also committed to providing the highest level of continuing medical education and clinical support to enable the appropriate use of C3's tissue engineered products.